Skip to main content
Equibles

William F. Ciambrone

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About William F. Ciambrone

Sarepta Therapeutics, Inc. reported in an 8-K filed November 2, 2022 that William F. Ciambrone resigned as Executive Vice President, Technical Operations, effective December 31, 2022. The proxy statement of Sarepta Therapeutics, Inc. reports total compensation of $5,046,221 for William F. Ciambrone in fiscal 2021, including a base salary of $494,092. Disclosed compensation is on record for 5 fiscal years.

“On October 31, 2022, William F. Ciambrone informed Sarepta Therapeutics, Inc. (the "Company") of his resignation from his position as the Company's Executive Vice President, Technical Operations, effective as of December 31, 2022.”
Sarepta Therapeutics, Inc. Form 8-K, filed November 2, 2022 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2021 Sarepta Therapeutics, Inc. (SRPT) $494,092 $5,046,221
2020 Sarepta Therapeutics, Inc. (SRPT) $458,179 $680,419
2019 Sarepta Therapeutics, Inc. (SRPT) $51,346 $4,345,194
2018 Sarepta Therapeutics, Inc. (SRPT) — —
2017 Sarepta Therapeutics, Inc. (SRPT) — —

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.